Mangalam Drugs

MANGALAM26 Apr 2024

Pharmaceuticals

₹

-0.05 (-0.05%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Mangalam Drugs

Mangalam Drugs

Pharmaceuticals

MANGALAM26 Apr 2024

₹

-0.05 (-0.05%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
12-Dec-2017	D	Declaration of Interim Dividend for the financial year 2017-18 Mangalam Drugs & Organics Ltd has informed BSE that the Board of Directors of the Company at their meeting held on December 12, 2017 has declared an interim dividend of 50 paise (Fifty paise only) per equity share having face value of Rs. 10/- each (i.e. 5%) on the equity shares of the Company for the financial year 2017-18. This is to inform that you that Company has fixed the Record Date as 22nd December, 2017 for the purpose of eligibility for payment of Interim Dividend.	21-Dec-2017
13-Jun-2005	D	2% Interim Dividend	30-Aug-2005
19-Apr-2024	BC	Source: BSE Announcement PDF	19-Apr-2024
08-Mar-2024	BC	MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/03/2024 inter alia to consider and approve The proposal of Scheme of Merger	15-Mar-2024
02-Mar-2024	BC	Source: BSE Announcement PDF	01-Mar-2024
06-Feb-2024	BC	MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve the unaudited standalone and con	13-Feb-2024
13-Feb-2024	BC	Source: BSE Announcement PDF	13-Feb-2024

No Rights has been declared by MANGALAM

Book Closure

Record Date	Split Date	Purpose
19-Apr-2024	01 Jan'1900	Source: BSE Announcement PDF
15-Mar-2024	-	MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/03/2024 inter alia to consider and approve The proposal of Scheme of Merger
01-Mar-2024	01 Jan'1900	Source: BSE Announcement PDF
13-Feb-2024	-	MANGALAM DRUGS & ORGANICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve the unaudited standalone and con
13-Feb-2024	01 Jan'1900	Source: BSE Announcement PDF

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Mangalam Drugs and Organics Ltd ₹100.70(-0.05/-0.05%)	100.70	-0.05	159.39	-12.74	0.00	1.15
Lupin Ltd ₹1,615.95(+21.55/1.35%)	1,615.95	+21.55	73,646.94	128.34	35.73	3.82
Ipca Laboratories Ltd ₹1,338.50(+10.05/0.76%)	1,338.50	+10.05	33,958.31	90.83	61.69	5.47
J B Chemicals & Pharmaceuticals Ltd ₹1,865.05(+2.25/0.12%)	1,865.05	+2.25	28,944.61	77.48	57.14	10.78
Sanofi India Ltd ₹8,274.15(+120.75/1.48%)	8,274.15	+120.75	19,055.37	38.57	32.28	18.77
IOL Chemicals & Pharmaceuticals Ltd ₹399.50(-0.85/-0.21%)	399.50	-0.85	2,345.28	-2.77	13.60	1.48

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	97.05	81.37	87.00	90.27	62.93	106.37
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	97.05	81.37	87.00	90.27	62.93	106.37
Other Operating Income	0.29	0.19	0.46	0.84	0.39	1.96
Other Income	0.00	0.03	0.02	0.29	0.13	0.00
Total Income	97.34	81.58	87.49	91.40	63.46	108.33
Total Expenditure	90.36	79.36	90.94	90.86	56.86	99.89
PBIDT	6.98	2.22	-3.45	0.53	6.60	8.43
Interest	3.31	3.24	3.41	3.43	3.22	2.56
PBDT	3.67	-1.02	-6.87	-2.90	3.39	5.88
Depreciation	3.62	3.73	3.42	2.75	2.88	2.76
Tax	-0.11	0.11	0.00	-2.28	-0.12	1.05
Deferred Tax	-0.35	-1.30	-0.75	1.02	0.20	-0.15
Reported Profit After Tax	0.50	-3.56	-9.54	-4.39	0.43	2.23
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.50	-3.56	-9.54	-4.39	0.43	2.23

EPS (Unit Curr.)	0.32	-2.25	-6.02	-2.77	0.27	1.41
EPS (Adj) (Unit Curr.)	0.32	-2.25	-6.02	-2.77	0.27	1.41
Calculated EPS (Unit Curr.)	0.32	-2.25	-6.02	-2.77	0.27	1.41
Calculated EPS (Adj) (Unit Curr.)	0.32	-2.25	-6.02	-2.77	0.27	1.41
Calculated EPS (Ann.) (Unit Curr.)	1.26	-9.00	-24.10	-11.08	1.08	5.63
Calculated EPS (Adj) (Ann.) (Unit Curr.)	1.26	-9.00	-24.10	-11.08	1.08	5.63
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	15.83	15.83	15.83	15.83	15.83	15.83
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	7.19	2.73	-3.97	0.59	10.49	7.93
PBDTM(%)	3.78	-1.25	-7.90	-3.21	5.39	5.53
PATM(%)	0.52	-4.38	-10.97	-4.86	0.68	2.10

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	15.83	15.83	15.83	15.83	15.83	15.83
Reserves Total	136.13	134.73	114.96	88.11	79.83	87.94
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	151.96	150.56	130.79	103.94	95.66	103.77
Secured Loans	74.42	78.39	62.55	49.78	58.62	64.65
Unsecured Loans	14.13	9.52	7.16	2.20	6.60	4.28
Total Debt	88.55	87.91	69.71	51.98	65.22	68.93
Total Liabilities	240.51	238.47	200.50	155.92	160.88	172.70
APPLICATION OF FUNDS :
Gross Block	236.91	220.30	196.69	170.92	165.15	156.14
Less : Accumulated Depreciation	94.54	85.34	78.88	69.85	61.66	54.23
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	142.37	134.96	117.81	101.07	103.49	101.91
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	9.49	5.71	6.35	1.24	0.20	0.07
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.22	0.22	0.24	0.24
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	137.47	117.11	58.59	64.84	73.45	60.13
Sundry Debtors	46.53	46.49	54.31	39.98	17.63	45.21
Cash and Bank	2.69	1.95	0.59	1.63	1.43	0.43
Loans and Advances	19.90	19.48	20.43	12.72	12.52	17.07
Total Current Assets	206.58	185.03	133.92	119.17	105.04	122.84
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	100.59	69.25	49.03	61.64	35.55	41.35
Provisions	1.72	3.27	0.40	0.83	0.59	0.71
Total Current Liabilities	102.31	72.52	49.44	62.46	36.14	42.06
Net Current Assets	104.27	112.51	84.49	56.71	68.90	80.78
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.73	1.11	0.33	1.60	1.60
Deferred Tax Liability	14.52	14.23	15.29	12.62	15.93	13.63
Net Deferred Tax	-14.52	-13.50	-14.18	-12.29	-14.33	-12.03
Total Assets	241.60	239.68	194.70	146.95	158.50	170.97
Contingent Liabilities	26.43	45.81	9.61	7.28	6.91	1.96

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	1.95	0.58	1.62	1.43	0.43
Net Cash from Operating Activities	39.52	25.71	27.55	30.55	21.69
Net Cash Used In Investing Activities	-22.17	-27.33	-31.29	-6.87	-9.26
Net Cash Used In Financing Activities	-16.62	2.98	2.70	-23.48	-11.43
Net Inc./Dec In Cash And Cash Equivalents	0.73	1.36	-1.04	0.20	1.00
Cash And Cash Equivalents At End Of The Year	2.68	1.95	0.58	1.63	1.43

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

50.32%

FII Shareholding

0.26%

DII Shareholding

0.00%

Public Shareholding

49.42%

**Promoter pledged shareholding 50.32%

About Mangalam Drugs and Organics Ltd

Mangalam Drugs and Organics Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 159.3 crores. It has reported a sales of Rs. 97.05 crores and a net profit of Rs. 0.5 crores for the quarter ended December 2018. The company management includes Govardhan M Dhoot, Govardhan M Dhoot,Brijmohan Dhoot,Rukmesh P. Dhandhania,Nidhi S. Mundada,Praveen Saxena,Jayant Barde,Rakesh K. Milwani (Mangalam Drugs and Organics Ltd) among others.

Chairman

Govardhan M Dhoot

Registered office

3rd Floor Rupam Building,239 P D Mello Road,Mumbai,Maharashtra,400001

FAX :91-22-26190900

Background

Incorporation Year1972

Face Value₹10

Market Lot1

How to buy Mangalam Drugs shares on nse?

To buy Mangalam Drugs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Mangalam Drugs share price today?

The Mangalam Drugs shares price on nse is Rs.100.7 today.

What is the market cap of Mangalam Drugs shares on NSE ?

The company has a market capitalization of Rs.159.39Cr

What is the PE & PB ratio of Mangalam Drugs shares ?

PE is 0 and PB is 1.15

What is the 52 Week High and Low of Mangalam Drugs shares?

Mangalam Drugs stock price high: Rs.132.45 Mangalam Drugs stock price low: Rs.90.8